Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Buy
22,075
+9,145
+71% +$163K ﹤0.01% 2665
2026
Q1
$246K Buy
+12,930
New +$250K ﹤0.01% 2750
2025
Q4
– Sell
-13,482
Closed -$253K – 3037
2025
Q3
$253K Buy
+13,482
New +$242K ﹤0.01% 2394
2024
Q3
– Sell
-14,108
Closed -$248K – 2605
2024
Q2
$248K Buy
14,108
+603
+4% +$12.5K ﹤0.01% 1918
2024
Q1
$347K Buy
+13,505
New +$339K ﹤0.01% 1786
2022
Q2
– Sell
-7,821
Closed -$235K – 1249
2022
Q1
$235K Buy
+7,821
New +$244K ﹤0.01% 817

Other funds holding XP

Cerity Partners's XP Position: Q2 2026 in Review

Cerity Partners increased its XP (XP) stake by 71% in Q2 2026, buying an estimated $163K and bringing the position to 22,075 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

Cerity Partners first reported a position in XP in Q1 2022 and has held it in 6 quarters since. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Cerity Partners held 22,075 shares of XP worth $359K as of Q2 2026.
  • Cerity Partners bought 9,145 XP shares in Q2 2026, an estimated $163K.
  • XP made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2665 holding.
  • Cerity Partners first reported a position in XP in Q1 2022 and has held it in 6 quarters since.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.